Skip Navigation



Carcinogenesis Advance Access published online on February 23, 2006
Carcinogenesis, doi:10.1093/carcin/bgi365
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
27/8/1607    most recent
bgi365v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Davies, R. A.
Right arrow Articles by Olynyk, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, R. A.
Right arrow Articles by Olynyk, J. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received June 19, 2005
Revised November 9, 2005
Accepted February 11, 2006

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor

Richard A. Davies 1, Belinda Knight 2, Yan Wu Tian 2, George C. T. Yeoh 3, and John K. Olynyk 4 *

1 University of Western Australia Centre for Medical Research, Western Australian Institute for Medical Research, Western Australia; School of Medicine & Pharmacology, University of Western Australia, Crawley, 6009, Western Australia; School of Biomedical and Chemical Sciences, University of Western Australia, Crawley, 6009, Western Australia
2 University of Western Australia Centre for Medical Research, Western Australian Institute for Medical Research, Western Australia; School of Medicine & Pharmacology, University of Western Australia, Crawley, 6009, Western Australia
3 University of Western Australia Centre for Medical Research, Western Australian Institute for Medical Research, Western Australia; School of Biomedical and Chemical Sciences, University of Western Australia, Crawley, 6009, Western Australia
4 University of Western Australia Centre for Medical Research, Western Australian Institute for Medical Research, Western Australia; School of Medicine & Pharmacology, University of Western Australia, Crawley, 6009, Western Australia; Department of Gastroenterology, Fremantle Hospital, Fremantle, 6162, Western Australia

* To whom correspondence should be addressed.
John K. Olynyk, E-mail: jolynyk{at}cyllene.uwa.edu.au


  Abstract

Oval cell proliferation precedes neoplasia in many rodent models of hepatocellular carcinoma and prevention of this proliferative response can reduce the risk of subsequent carcinoma. This study aimed to determine whether a selective cyclo-oxygenase-2 (COX-2) inhibitor, SC-236, affects (1) the oval cell response to liver injury in a mouse model of hepatocarcinogenesis and (2) an oval cell line. Four-week-old mice were fed either normal chow or a choline deficient, ethionine supplemented (CDE) diet in the presence or absence of SC-236. Liver histology and oval cell numbers were determined after 2, 4, 12 and 52 weeks of treatment. Oval cells were scored using morphological criteria and positive immuno-staining for the M2-isozyme of pyruvate kinase (M2PK) or A6. An immortalised oval cell line (PIL-2) was used to study the in vitro effects of SC-236 on oval cell proliferation, apoptosis and Akt phosphorylation. The percentage of M2PK-positive oval cells and COX-2 positive cells was reduced by 80% and 45%, respectively, in CDE-fed mice receiving SC-236 compared with CDE-fed animals not receiving SC-236. Some M2PK positive oval cells were also COX-2 positive. The percentage of A6-positive cells was not affected by SC-236 administration to CDE fed mice. Administration of SC-236 increased apoptosis as evidenced by a 73% increase in the number of TUNEL-positive cells at 2 weeks in CDE fed mice. Primary oval cells and PIL-2 cells expressed COX-2. In vitro treatment of PIL-2 cells with SC-236 resulted in a dose-dependent preferential death of A6-negative cells. Administration of 25 and 50 µM Prostaglandin E2 partially attenuated SC-236 induced cell death by 25%. In vitro oval cell death was associated with apoptosis and a 70% reduction in Akt phosphorylation. These results suggest that the SC-236 induced reduction of M2PK-positive oval cell numbers may be due to COX-2 dependant inhibition of Akt phosphorylation and induction of apoptosis.

Keywords: Liver regeneration; Hepatic progenitor cell; Akt; Apoptosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
H. Strick-Marchand, G. X. Masse, M. C. Weiss, and J. P. Di Santo
Lymphocytes Support Oval Cell-Dependent Liver Regeneration
J. Immunol., August 15, 2008; 181(4): 2764 - 2771.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. K. Sicklick, S. S. Choi, M. Bustamante, S. J. McCall, E. H. Perez, J. Huang, Y.-X. Li, M. Rojkind, and A. M. Diehl
Evidence for epithelial-mesenchymal transitions in adult liver cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G575 - G583.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.